AzTrials
AzTrials

Young Adult-Mediated Intervention to Increase Colorectal Cancer ScreeningNCT05936931

Young Adult-Mediated Intervention to Increase Colorectal Cancer Screening

A study testing Changes in CRC screening awareness and intentions in people with Young Adult-Mediated Intervention to Increase Colorectal Cancer Screening, run by Virginia Commonwealth University at 1 site in United States.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record

Search all trials

Trial summary

This study will garner preliminary data to develop a young adult-mediated intervention whereby a younger family member encourages their older family member to get colorectal cancer (CRC) screening. Read more about this study

Who is it for?
Ages 25 to 75 yearsHealthy volunteers can take part
What is being tested?
Changes in CRC screening awareness and intentions
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteUnited States
Study dates
30 Nov 2026to 31 Dec 2029
Phase
Interventional

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 25 to 75 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Residents of counties in the Virginia/North Carolina CRC hotspot
  • 25-75 years old
  • Able to speak, write, and comprehend English
  • Younger adult participants in Aims 3 must have an older, screening age-eligible relative with whom they speak with regularly (i.e., ≥ once every two weeks)

Who cannot join

  • Participants in Aims 1 or 2 will be ineligible for Aim 3

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Carrie A Miller, PhD, MPH contact

(804) 628-8188

carrie.a.miller@vcuhealth.org

United States1 site
  • Virginia Commonwealth University

    Richmond, Virginia, 23289

    Carrie Miller, Ph.D, 804-347-9054, glassmanca@vcu.edu

    Carrie Miller, Ph.D

Other trials in United States

About this study

Official title: Developing a Young Adult-Mediated Intervention to Increase Colorectal Cancer Screening Among Rural Screening Age-Eligible Adults

This study will garner preliminary data to develop a young adult-mediated intervention whereby a younger family member encourages their older family member to get colorectal cancer (CRC) screening. In Aim 1, survey data from n=150 younger (25-44 years old) and n=150 older (45-75 years old) adults living in rural communities will be collected. In Aim 2, intervention components will be evaluated using n=9 focus groups. The novel intervention will be assessed via a pilot trial (n=15 adult child/parent dyads) in Aim 3.

Read the detailed description

Aim 1. Environmental Scan of Health Communications Landscape. Using quantitative methods, examine the health communications landscape of younger (25-44 years old) and older (45-75 years old) adults living in rural communities. N=300 survey responses (n=150 from each age group) will be analyzed to determine the primary channels and sources of health-related information, quantify the extent to which these residents engage in family communications about cancer screening, and identify potential strategies for upward communications. Individual factors (i.e., CRC screening knowledge, health literacy, and numeracy) and specific facilitators of and barriers to upward communication about CRC screening will be also assessed.

Aim 2. Message Development and Refinement. Using qualitative methods, develop and evaluate intervention components to facilitate effective upward communications about CRC prevention and screening. To accomplish this aim, we will: 1) use findings from Aim 1 to design intervention content and materials that leverage relevant communication channels and strategies, and address barriers to upward communication and 2) conduct n=9 focus groups with adult children 25-44 years of age (n=3), CRC screening age-eligible adults, 45-75 years old (n=3), and adult child/parent dyads (n=3), to assess message acceptability and refine key content areas. We will iterate and modify intervention components based on feedback.

Aim 3. Preliminary Testing. Using a single arm, open-label, pre-test post-test design (n=15 adult child/parent dyads), assess the impact of a young adult-mediated intervention to increase CRC screening among a paired age-eligible family member (e.g., parent/grandparent). The focus of the intervention will be on changes in CRC screening awareness and intentions among the age-eligible adult, but we hypothesize that the young adult could benefit as well. Thus, in addition to assessing feasibility and acceptability, we will assess changes in 1) CRC screening intentions among the age-eligible adults and 2) CRC health literacy and awareness of screening guidelines among the younger adult participant.

Being tested
Changes in CRC screening awareness and intentions

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Changes in CRC screening awareness and intentionsBehavioural

    Using a single arm, open-label, pre-test post-test design (n=15 adult child/parent dyads), assess the impact of a young adult-mediated intervention to increase CRC screening among a paired age-eligible family member (e.g., parent/grandparent). The focus of the intervention will be on changes in CRC screening awareness and intentions among the age-eligible adult, but we hypothesize that the young adult could benefit as well. Thus, in addition to assessing feasibility and acceptability, we will assess changes in 1) CRC screening intentions among the age-eligible adults and 2) CRC health literacy and awareness of screening guidelines among the younger adult participant.

Study groups in NCT05936931
Study groupRoleWhat they receive
Aim 3: Single arm, open-label, pre-test/post-test design pilot trialOtherSingle arm, open-label, pre-test/post-test design pilot trial
Receives: Behavioral: Changes in CRC screening awareness and intentions

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. CRC screening knowledge and awareness

    A composite index score on four awareness items and 14 knowledge items adopted from prior research

    Measured: 2-months post-intervention

  2. CRC screeningintentions

    A single item, based on previous CRC screening research

    Measured: 2-months post-intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Jul 2023
  2. Study start30 Nov 2026 (estimated)
  3. Primary completion31 Jan 2029 (estimated)
  4. Study completion31 Dec 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Screening
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05936931
Sponsor's protocol ID
IRB202300089
Other IDs
R03CA270837-01A1, HM20026698
Status last verified
Oct 2026
First submitted
23 Jun 2023
Last updated
21 Oct 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: There are no plans to share individual patient data.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in